BARCELONA, Spain, May 2, 2018 /PRNewswire/ — NMT2 announces the further expansion of the NobleStitch™ EL with the addition of Hospitals in Barcelona, the first to perform PFO closure cases in Spain has been Vall Hebron Hospital. Dr. Gerard Marti, Consultant in Interventional Cardiology and Structural Heart disease at the Hospital Vall Hebron was the first in Spain to perform the NobleStitch™ procedure […]
Tag: PFO
NobleStitch™ EL Italian Registry Data Published In EuroIntervention
ROME, April 9, 2018 /PRNewswire/ — Nobles Medical Technologies II, Inc. (NMT2) has announced the first peer-reviewed publication of data for PFO closure using the NobleStitch™ EL. The first systematic clinical experience by using the revolutionary “deviceless” technique to close Patent Foramen Ovale (PFO) has been recently published in the prestigious peer-reviewed European journal EuroIntervention the official journal […]
HeartStitch® Leading the growth of PFO Closure in Italy
MILAN, Dec. 11, 2017 /PRNewswire/ — Kardia announced expansion plan of the NobleStitch™ EL at a recent meeting organized by Professor Francesco Romeo at Policlinico Tor Vergata in Rome where Prof. Achille Gaspardone performed a successful NobleStitch™ EL live case that was transmitted to the attendees in Ayla Magna, Rome, Italy. PFO (PRNewsfoto/HeartStitch) Prof. Gaspardone, who recently presented 2 studies (The Italian/ Swedish Registry of NobleStitch™ […]
Gore Announces Positive Results from REDUCE Clinical Study for PFO Closure
Study met its primary endpoint with PFO closure in conjunction with antiplatelet therapy, reducing recurrent stroke by > 75% over antiplatelet therapy alone Share: Twitter Linked In Source W. L. Gore Press Release FLAGSTAFF, Ariz. (May 16, 2017) – W. L. Gore & Associates, Inc. (Gore) announces positive results from its REDUCE Study assessing closure of […]
W. L. Gore & Associates Announces Positive Results From REDUCE Clinical Study For PFO Closure
FLAGSTAFF, Ariz.–(BUSINESS WIRE)–W. L. Gore & Associates, Inc. (Gore) announces positive results from its REDUCE Study assessing closure of patent foramen ovale (PFO) for the reduction of recurrent ischemic stroke and new brain infarct. The data were shared May 16 at the European Stroke Organisation Conference (ESOC) in Prague, Czech Republic. Gore plans to submit […]